US3998973A
(en)
|
1975-04-07 |
1976-12-21 |
R. T. Vanderbilt Company, Inc. |
Thickening composition
|
FR2339392A1
(fr)
|
1976-02-02 |
1977-08-26 |
Oreal |
Compositions contenant des derives du silicium
|
GB2050160A
(en)
|
1979-04-10 |
1981-01-07 |
Nottage H C |
Cosmetic protective cream
|
FR2471778A1
(fr)
|
1979-12-21 |
1981-06-26 |
Oreal |
Procede de traitement des cheveux en vue d'ameliorer leur aspect a l'aide d'une composition contenant un hydrolysat de lactalbumine
|
EP0126138A1
(en)
|
1982-11-04 |
1984-11-28 |
Redken Laboratories Inc. |
Cosmetic preparation
|
GB8320366D0
(en)
|
1983-07-28 |
1983-09-01 |
Gillette Co |
Hair relaxing compositions
|
GB8421112D0
(en)
|
1984-08-20 |
1984-09-26 |
Unilever Plc |
Pyroglutamic acid esters
|
GB8600568D0
(en)
|
1986-01-10 |
1986-02-19 |
Gillette Co |
Hair relaxing compositions
|
US4831023A
(en)
|
1986-06-27 |
1989-05-16 |
Thames Pharmacal Co., Inc. |
Water washable vehicles for topical use
|
US4837019A
(en)
|
1986-08-11 |
1989-06-06 |
Charles Of The Ritz Group Ltd. |
Skin treatment composition and method for treating burned skin
|
DE3805744C2
(de)
|
1987-03-04 |
1999-09-23 |
Novartis Ag |
Phenylcarbamate zur Hemmung der Acetylcholinesterase
|
US4720353A
(en)
|
1987-04-14 |
1988-01-19 |
Richardson-Vicks Inc. |
Stable pharmaceutical w/o emulsion composition
|
DE3714140A1
(de)
|
1987-04-28 |
1988-11-10 |
Lohmann Therapie Syst Lts |
Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
|
US4906475A
(en)
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
JPH02145512A
(ja)
|
1988-11-26 |
1990-06-05 |
Shin Etsu Chem Co Ltd |
被膜形成型外用剤
|
US5122519A
(en)
|
1989-06-27 |
1992-06-16 |
American Cyanamid Company |
Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
|
DE4131678A1
(de)
|
1991-04-13 |
1992-10-15 |
Beiersdorf Ag |
Stabile multiple emulsionen
|
AU2259692A
(en)
|
1991-07-03 |
1993-02-11 |
Sano Corporation |
Composition and method for transdermal delivery of diclofenac
|
US5300286A
(en)
|
1992-07-14 |
1994-04-05 |
Dow Corning Corporation |
Silicone emulsion for personal care application
|
US5210103A
(en)
|
1992-09-02 |
1993-05-11 |
Basf Corporation |
Volatile silicone oil-blown integral skin foam
|
US5698589A
(en)
|
1993-06-01 |
1997-12-16 |
International Medical Innovations, Inc. |
Water-based topical cream containing nitroglycerin and method of preparation and use thereof
|
GB9315755D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized formulation
|
FR2709131B1
(fr)
|
1993-08-18 |
1995-11-10 |
Cilag Laboratoire |
Dispositif de distribution d'une substance thérapeutique ou cosmétique dont le véhicule inerte est un polydiorganosiloxane volatil, et composition destinée à être utilisée dans le dispositif.
|
US5466823A
(en)
|
1993-11-30 |
1995-11-14 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides
|
US5620692A
(en)
|
1993-12-23 |
1997-04-15 |
Nurture, Inc. |
Oat oil compositions with useful cosmetic and dermatological properties
|
GB9404248D0
(en)
|
1994-03-05 |
1994-04-20 |
Boots Co Plc |
Pharmaceutical formulations
|
US5451405A
(en)
|
1994-04-25 |
1995-09-19 |
Chesebrough-Pond's Usa Co. |
Skin treatment composition
|
IL116539A
(en)
|
1995-01-06 |
2002-02-10 |
Noven Pharma |
Preparations given through the skin of unstable anti-acid drugs
|
FR2738565B1
(fr)
|
1995-09-13 |
1997-11-28 |
Dior Christian Parfums |
Produits extraits d'une plante du genre commiphora, en particulier de la plante commiphora mukul, et extraits en contenant et leurs applications notamment en cosmetique
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
AU2456097A
(en)
|
1996-05-21 |
1997-12-09 |
Dermasciences, Inc. |
Topical barrier composition containing silicone and bentonite
|
GB9611167D0
(en)
|
1996-05-29 |
1996-07-31 |
Glaxo Group Ltd |
Medicaments
|
ES2165614T3
(es)
|
1996-06-28 |
2002-03-16 |
Unilever Nv |
Composiciones fluidas desodorantes/antitranspirantes.
|
FR2751874B1
(fr)
|
1996-08-02 |
1998-08-28 |
Sederma Sa |
Nouvelles compositions cosmetiques pour embellir et eclaircir la peau
|
GB9618974D0
(en)
|
1996-09-11 |
1996-10-23 |
Glaxo Group Ltd |
Medicaments
|
US5747051A
(en)
|
1996-09-27 |
1998-05-05 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
|
US5756109A
(en)
|
1996-09-27 |
1998-05-26 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Skin care compositions containing geranyl geraniol and retinol or retinyl esters
|
US5955097A
(en)
|
1996-10-18 |
1999-09-21 |
Virotex Corporation |
Pharmaceutical preparation applicable to mucosal surfaces and body tissues
|
US6019997A
(en)
|
1997-01-09 |
2000-02-01 |
Minnesota Mining And Manufacturing |
Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
|
DE19700913C2
(de)
|
1997-01-14 |
2001-01-04 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur Abgabe von Hormonen
|
FR2763842B1
(fr)
|
1997-05-27 |
2000-09-15 |
Sederma Sa |
Compositions cosmetiques ou dermopharmaceutiques contenant des derives de threonine ou de serine
|
FR2768335B1
(fr)
|
1997-09-12 |
2000-03-03 |
Sederma Sa |
Compositions a usage cosmetique ou dermopharmaceutique contenant une association d'extrait d'algue et d'exopolysaccharide
|
IL122084A
(en)
|
1997-10-31 |
1999-09-22 |
Lurident Ltd |
Formulation for personal care with mucoadhesive properties
|
DE19750030A1
(de)
|
1997-11-12 |
1999-05-20 |
Merck Patent Gmbh |
Lichtstabile kosmetische Formulierung enthaltend Butylmethoxydibenzoylmethan
|
DE19750029A1
(de)
|
1997-11-12 |
1999-05-20 |
Merck Patent Gmbh |
Stabile kosmetische Formulierung enthaltend Butylmethoxydibenzoylmethan
|
US6187300B1
(en)
|
1997-12-17 |
2001-02-13 |
The Procter & Gamble Company |
Antiperspirant cream compositions having improved wash-off and antiperspirant efficacy
|
US5851544A
(en)
|
1997-12-18 |
1998-12-22 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide
|
US20060015058A1
(en)
|
1998-01-08 |
2006-01-19 |
Kellogg Scott C |
Agents and methods for enhancement of transdermal transport
|
AU5547099A
(en)
|
1998-08-03 |
2000-02-28 |
Epigenesis Pharmaceuticals, Inc. |
A new analgesic, anti-inflammatory and wound healing agent
|
US6284234B1
(en)
|
1998-08-04 |
2001-09-04 |
Johnson & Johnson Consumer Companies, Inc. |
Topical delivery systems for active agents
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
GB9828379D0
(en)
|
1998-12-22 |
1999-02-17 |
Unilever Plc |
Skin care composition
|
US6007829A
(en)
|
1998-12-17 |
1999-12-28 |
Cheesebrough-Pond's Usa Co. |
Cosmetic skin care compositions containing succinate compounds
|
FR2791887B1
(fr)
|
1999-04-06 |
2004-04-23 |
Sederma Sa |
Compositions cosmetiques ou dermopharmaceutiques renfermant des extraits vegetaux de pinus lambertania contre la secheresse cutanee de toute origine
|
HU230045B1
(hu)
|
1999-04-23 |
2015-06-29 |
Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) |
Bőrgyógyászati alkalmazásra szolgáló nem vizes gyógyszerkészítmény
|
KR100319473B1
(ko)
|
1999-08-24 |
2002-01-05 |
김강권 |
실크아미노산 수용액을 주재로한 아이스크림류의 제조방법
|
US10179159B2
(en)
|
1999-10-22 |
2019-01-15 |
Scott Wepfer |
Topical anesthetic formulation
|
FR2802097B1
(fr)
|
1999-12-14 |
2002-12-13 |
Invest S Therapeutiques Essais |
Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication
|
US20050074487A1
(en)
|
1999-12-16 |
2005-04-07 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
US6432415B1
(en)
|
1999-12-17 |
2002-08-13 |
Axrix Laboratories, Inc. |
Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
|
DE10004790B4
(de)
|
2000-02-01 |
2004-09-09 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
|
US6361806B1
(en)
|
2000-02-23 |
2002-03-26 |
Michael P. Allen |
Composition for and method of topical administration to effect changes in subcutaneous adipose tissue
|
ES2290120T3
(es)
|
2000-03-17 |
2008-02-16 |
Avocet Polymer Technologies, Inc. |
Procedimientos para mejorar la dimension y el aspecto de una herida.
|
US6800297B2
(en)
|
2000-06-15 |
2004-10-05 |
Acusphere, Inc. |
Porous COX-2 inhibitor matrices and methods of manufacture thereof
|
US6589557B2
(en)
|
2000-06-15 |
2003-07-08 |
Acusphere, Inc. |
Porous celecoxib matrices and methods of manufacture thereof
|
DE10032132A1
(de)
|
2000-07-01 |
2002-01-17 |
Lohmann Therapie Syst Lts |
Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
|
IN191090B
(no)
*
|
2000-08-29 |
2003-09-20 |
Ranbanx Lab Ltd |
|
DE10042411A1
(de)
|
2000-08-30 |
2002-03-28 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur Abgabe von Exemestan
|
DE10042412B4
(de)
|
2000-08-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
|
GB0027769D0
(en)
|
2000-11-14 |
2000-12-27 |
Unilever Plc |
Cosmetic method of treating skin
|
GB0028355D0
(en)
|
2000-11-21 |
2001-01-03 |
Unilever Plc |
Cosmetic method of treating skin
|
GB0028706D0
(en)
|
2000-11-24 |
2001-01-10 |
Unilever Plc |
Cosmetic composition
|
US8449908B2
(en)
|
2000-12-22 |
2013-05-28 |
Alltranz, Llc |
Transdermal delivery of cannabidiol
|
CA2448627A1
(en)
|
2001-05-31 |
2002-12-05 |
Pharmacia Corporation |
Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
|
GB0119583D0
(en)
|
2001-08-10 |
2001-10-03 |
Unilever Plc |
Cosmetic composition and method of treating skin
|
WO2003035080A2
(en)
*
|
2001-08-28 |
2003-05-01 |
Ranbaxy Laboratories Limited |
A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
|
US20030104019A1
(en)
|
2001-11-01 |
2003-06-05 |
Mcculloch Laura |
Composition for reducing enzymatic irritation to skin
|
DE10164531A1
(de)
|
2001-12-31 |
2003-07-17 |
Pharmatech Gmbh |
Zubereitung zur Oberflächenanästhesie der Haut
|
US6838078B2
(en)
|
2002-01-16 |
2005-01-04 |
3M Innovative Properties Company |
Film-forming compositions and methods
|
US20030180281A1
(en)
|
2002-03-11 |
2003-09-25 |
Bott Richard R. |
Preparations for topical skin use and treatment
|
CA2479665C
(en)
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20030199584A1
(en)
|
2002-04-11 |
2003-10-23 |
Ahluwalia Gurpreet S. |
Reduction of hair growth
|
US20030199537A1
(en)
|
2002-04-18 |
2003-10-23 |
Cannon John B. |
Polymorph of a pharmaceutical
|
JP2004075592A
(ja)
|
2002-08-14 |
2004-03-11 |
Masahiko Abe |
非イオン性ベシクルおよびその利用
|
CH696420A5
(de)
|
2002-09-13 |
2007-06-15 |
Mepha Ag |
Neue stabile Zubereitungen von Alkyl-, Phenyl-Pyridonen für topische Anwendung.
|
US7138394B2
(en)
|
2002-09-27 |
2006-11-21 |
Alpharx Inc. |
Vehicle for topical delivery of anti-inflammatory compounds
|
US20060241175A1
(en)
|
2002-09-27 |
2006-10-26 |
Joseph Schwarz |
Vehicle for topical delivery of anti-inflammatory compounds
|
US20060159648A1
(en)
|
2003-02-17 |
2006-07-20 |
Davis Adrian F |
Novel therapeutic method and compositions for topical administration
|
JP2006523735A
(ja)
|
2003-04-18 |
2006-10-19 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
抗菌顔料
|
ITRM20030204A1
(it)
|
2003-04-29 |
2004-10-30 |
Provincia Italiana Della Congregazi One Dei Figli |
Formulazione dermatologica.
|
FR2854897B1
(fr)
|
2003-05-12 |
2007-05-04 |
Sederma Sa |
Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
|
WO2004112837A1
(ja)
|
2003-05-23 |
2004-12-29 |
Hisamitsu Pharmaceutical Co., Inc. |
非ステロイド系消炎鎮痛剤含有外用経皮製剤およびインターロイキン-1α生成抑制剤
|
WO2005000248A2
(en)
|
2003-06-25 |
2005-01-06 |
Geron Corporation |
Compositions and methods for skin conditioning
|
ES2237298B1
(es)
|
2003-07-16 |
2006-11-01 |
Italfarmaco, S.A. |
Formulaciones mucoadhesivas semisolidas.
|
WO2005007129A2
(en)
|
2003-07-17 |
2005-01-27 |
Angiotech International Ag |
Topical formulations with bioactive components
|
WO2005011567A2
(en)
|
2003-08-04 |
2005-02-10 |
Foamix Ltd. |
Foam carrier containing amphiphilic copolymeric gelling agent
|
WO2005016292A1
(en)
|
2003-08-07 |
2005-02-24 |
The Procter & Gamble Company |
Oil emulsions
|
WO2005044227A1
(en)
|
2003-11-05 |
2005-05-19 |
Glenmark Pharmaceuticals Limited |
Topical pharmaceutical compositions
|
WO2005046600A2
(en)
|
2003-11-07 |
2005-05-26 |
Nexmed Holdings, Inc. |
Transdermal tulobuterol delivery
|
FR2862871B1
(fr)
|
2003-12-01 |
2008-05-30 |
Camet Anne Dupouy |
Composition cosmetique anti-pollution
|
US20050255133A1
(en)
|
2004-05-11 |
2005-11-17 |
Alpharx Inc. |
Topical composition for acne treatment
|
US20050255131A1
(en)
|
2004-05-11 |
2005-11-17 |
Mohan Vishnupad |
Clindamycin compositions and delivery system therefor
|
US7662855B2
(en)
|
2004-05-11 |
2010-02-16 |
Imaginative Research Associates, Inc. |
Retinoid solutions and formulations made therefrom
|
KR20070072867A
(ko)
|
2004-09-01 |
2007-07-06 |
넥스메드 홀딩스 인코포레이티드 |
경피성 항구토 전달 시스템, 이의 방법 및 조성물
|
US20070267035A1
(en)
|
2004-09-07 |
2007-11-22 |
Henkel Kommanditgesellschaft Auf Aktien |
Composition and Method for the Smoothing of Fibres Containing Keratin
|
US8653055B2
(en)
|
2004-09-15 |
2014-02-18 |
Teva Animal Health, Inc. |
Corticosteroid having low systemic absorption
|
TW200616589A
(en)
|
2004-10-08 |
2006-06-01 |
Noven Pharma |
Transdermal delivery of drugs based on crystal size
|
WO2006091297A2
(en)
|
2005-02-23 |
2006-08-31 |
The Regents Of The University Of California |
Molecules to enhance percutaneous delivery and methods for discovery therefor
|
WO2006138035A1
(en)
|
2005-06-13 |
2006-12-28 |
Dow Corning Corporation |
Vehicle for the delivery of topical lipid soluble pharmaceutical agents
|
CA2618993A1
(en)
|
2005-08-13 |
2007-02-22 |
Collegium Pharmaceutical, Inc. |
Topical delivery with a carrier fluid
|
WO2007051596A1
(en)
|
2005-11-03 |
2007-05-10 |
Dsm Ip Assets B.V. |
Novel retinyl biotinates and use thereof
|
KR100658436B1
(ko)
|
2005-12-09 |
2006-12-27 |
한국화학연구원 |
아데노실코발라민 함유 피부질환 치료용 외용제 조성물
|
US20070243132A1
(en)
|
2005-12-22 |
2007-10-18 |
Apollo Life Sciences Limited |
Transdermal delivery of pharmaceutical agents
|
EP2162120B1
(en)
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
HU227970B1
(en)
*
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
HUP0900072A2
(hu)
|
2009-02-06 |
2010-09-28 |
Egis Gyogyszergyar Nyilvanosan |
Transzdermális gyógyszerkészítmények
|
WO2009010837A2
(en)
|
2007-07-13 |
2009-01-22 |
Pfizer Products Inc. |
Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer
|
JPWO2009031318A1
(ja)
|
2007-09-05 |
2010-12-09 |
興和株式会社 |
鎮痛・抗炎症剤含有外用剤
|
WO2009063367A1
(en)
|
2007-11-15 |
2009-05-22 |
Pfizer Products Inc. |
Dosage forms comprising celecoxib providing both rapid and sustained pain relief
|
WO2010047831A1
(en)
|
2008-10-23 |
2010-04-29 |
Nycomed Us Inc. |
Stable metronidazole gel formulations
|
JPWO2010103843A1
(ja)
|
2009-03-11 |
2012-09-13 |
興和株式会社 |
鎮痛・抗炎症剤含有外用剤
|
JPWO2010103845A1
(ja)
*
|
2009-03-11 |
2012-09-13 |
興和株式会社 |
鎮痛・抗炎症剤含有外用剤
|
EP2575813A1
(en)
*
|
2010-05-28 |
2013-04-10 |
Nuvo Research Inc. |
Topical etoricoxib formulation
|
US10045935B2
(en)
*
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|